No Data
Top Small-cap Stock Picks From Morgan Stanley Following the Group's Upgrade to Neutral
Viking Therapeutics Stock: Buy or Sell Before Q3 Earnings?
Viking Stock Rises 29% in Three Months: Time to Buy, Hold or Sell?
Earnings Preview: VKTX to Report Financial Results Post-market on October 23
$Viking Therapeutics(VKTX.US)$ is scheduled to release its financial results post-market on October 23 ET. Earnings PreviewAnalysts estimate $Viking Therapeutics(VKTX.US)$ to post revenue of USD0
Consumer, Labor Groups Urge FTC to Block Catalent Sale to Novo Nordisk - Report
Oppenheimer Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $138